{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:44:33Z","timestamp":1791225873276,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T00:00:00Z","timestamp":1624579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.cmi.2021.06.023","type":"journal-article","created":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T11:11:37Z","timestamp":1624705897000},"page":"1678-1684","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort"],"prefix":"10.1016","volume":"27","author":[{"given":"Juan","family":"Berenguer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"D\u00edez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Mart\u00edn-Vicente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Mic\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda J.","family":"P\u00e9rez-El\u00edas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio J.","family":"Garc\u00eda-Fraile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e9s","family":"Su\u00e1rez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Podzamczer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Del Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Pulido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.","family":"Iribarren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e9lix","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Poveda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Galera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"Izquierdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor","family":"Asensi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn","family":"Portilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 R.","family":"Arribas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Gonz\u00e1lez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"Resino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"Jarr\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2021.06.023_bib1","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2021.06.023_bib2","doi-asserted-by":"crossref","first-page":"m1985","DOI":"10.1136\/bmj.m1985","article-title":"Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study","volume":"369","author":"Docherty","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2021.06.023_bib3","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.cmi.2020.07.024","article-title":"Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain","volume":"26","author":"Berenguer","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2021.06.023_bib4","doi-asserted-by":"crossref","first-page":"E314","DOI":"10.1016\/S2352-3018(20)30111-9","article-title":"COVID-19 in HIV Investigators. COVID-19 in patients with HIV: clinical case series","volume":"7","author":"Blanco","year":"2020","journal-title":"Lancet HIV"},{"key":"10.1016\/j.cmi.2021.06.023_bib5","doi-asserted-by":"crossref","first-page":"e554","DOI":"10.1016\/S2352-3018(20)30164-8","article-title":"Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort","volume":"7","author":"Vizcarra","year":"2020","journal-title":"Lancet HIV"},{"key":"10.1016\/j.cmi.2021.06.023_bib6","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1093\/cid\/ciaa579","article-title":"Clinical features and outcomes of patients with human immunodeficiency virus with COVID-19","volume":"71","author":"Gervasoni","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2021.06.023_bib7","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1093\/cid\/ciaa657","article-title":"Hospitalized patients with COVID-19 and human immunodeficiency virus: a case series","volume":"71","author":"Childs","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2021.06.023_bib8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/QAI.0000000000002423","article-title":"Outcomes among HIV-positive patients hospitalized with COVID-19","volume":"85","author":"Karmen-Tuohy","year":"2020","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.cmi.2021.06.023_bib9","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1097\/QAD.0000000000002632","article-title":"Clinical characteristics, comorbidities and outcomes among persons with HIV hospitalized with coronavirus disease 2019 in Atlanta, Georgia","volume":"34","author":"Collins","year":"2020","journal-title":"AIDS"},{"key":"10.1016\/j.cmi.2021.06.023_bib10","article-title":"SARS-CoV-2 and HIV coinfection: clinical experience from Rhode Island, United States","volume":"23","author":"Byrd","year":"2020","journal-title":"J\u00a0Int AIDS Soc"},{"key":"10.1016\/j.cmi.2021.06.023_bib11","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1097\/QAD.0000000000002607","article-title":"Disproportionate burden of coronavirus disease 2019 among racial minorities and those in congregate settings among a large cohort of people with HIV","volume":"34","author":"Meyerowitz","year":"2020","journal-title":"AIDS"},{"key":"10.1016\/j.cmi.2021.06.023_bib12","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1097\/QAD.0000000000002651","article-title":"HIV infection and COVID-19: risk factors for severe disease","volume":"34","author":"Etienne","year":"2020","journal-title":"AIDS"},{"key":"10.1016\/j.cmi.2021.06.023_bib13","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1097\/QAD.0000000000002643","article-title":"Clinical characteristics, risk factors, and incidence of symptomatic coronavirus disease 2019 in a large cohort of adults living with HIV: a single-center, prospective observational study","volume":"34","author":"Inciarte","year":"2020","journal-title":"AIDS"},{"key":"10.1016\/j.cmi.2021.06.023_bib14","doi-asserted-by":"crossref","first-page":"536","DOI":"10.7326\/M20-3689","article-title":"Incidence and severity of COVID-19 in HIV-positive persons receiving antiretroviral therapy : a cohort study","volume":"173","author":"Del Amo","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cmi.2021.06.023_bib15","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1097\/QAD.0000000000002663","article-title":"Factors associated with hospital admission for COVID-19 in HIV patients","volume":"34","author":"Di Biagio","year":"2020","journal-title":"AIDS"},{"key":"10.1016\/j.cmi.2021.06.023_bib16","doi-asserted-by":"crossref","first-page":"F3","DOI":"10.1097\/QAD.0000000000002666","article-title":"Characteristics and outcomes of COVID-19 in patients with HIV: a multicentre research network study","volume":"34","author":"Hadi","year":"2020","journal-title":"AIDS"},{"key":"10.1016\/j.cmi.2021.06.023_bib17","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1093\/cid\/ciaa635","article-title":"Clinical characteristics and outcomes in people living with human immunodeficiency virus hospitalized for coronavirus disease 2019","volume":"71","author":"Shalev","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2021.06.023_bib18","first-page":"ciaa1198","article-title":"Risk factors for COVID-19 death in a population cohort study from the Western Cape Province, South Africa","author":"Boulle","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2021.06.023_bib19","article-title":"Outcomes of COVID-19 related hospitalization among people with HIV in the ISARIC WHO Clinical Characterization Protocol (UK): a prospective observational study","author":"Geretti","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2021.06.023_bib20","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1093\/cid\/ciaa880","article-title":"Coronavirus 2019 and people living with human immunodeficiency virus: outcomes for hospitalized patients in New York City","volume":"71","author":"Sigel","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2021.06.023_bib21","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1016\/S2352-3018(20)30305-2","article-title":"HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform","volume":"8","author":"Bhaskaran","year":"2021","journal-title":"Lancet HIV"},{"key":"10.1016\/j.cmi.2021.06.023_bib22","series-title":"COVID-19 in the largest US HIV cohort 23rd International AIDS Conference","author":"Park","year":"2020"},{"key":"10.1016\/j.cmi.2021.06.023_bib23","series-title":"Oxford specialist handbook of infectious disease epidemiology","author":"Abubakar","year":"2016"},{"key":"10.1016\/j.cmi.2021.06.023_bib24","doi-asserted-by":"crossref","first-page":"e245","DOI":"10.1016\/S1473-3099(20)30517-X","article-title":"Serology testing in the COVID-19 pandemic response","volume":"20","author":"Peeling","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2021.06.023_bib25","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(20)31483-5","article-title":"Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study","volume":"396","author":"Pollan","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2021.06.023_bib26","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1056\/NEJMoa2026116","article-title":"Humoral immune response to SARS-CoV-2 in Iceland","volume":"383","author":"Gudbjartsson","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2021.06.023_bib27","article-title":"Serologic testing of U.S. blood donations to identify SARS-CoV-2-reactive antibodies: december 2019\u2013January 2020","author":"Basavaraju","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2021.06.023_bib28","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0140-6736(20)31304-0","article-title":"Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study","volume":"396","author":"Stringhini","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2021.06.023_bib29","doi-asserted-by":"crossref","first-page":"104437","DOI":"10.1016\/j.jcv.2020.104437","article-title":"SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients","volume":"128","author":"Korth","year":"2020","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.cmi.2021.06.023_bib30","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1007\/s11606-020-05926-8","article-title":"Prevalence of SARS-CoV-2 antibodies among healthcare workers at a tertiary academic hospital in New York City","volume":"35","author":"Mansour","year":"2020","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.cmi.2021.06.023_bib31","first-page":"1","article-title":"Seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a London NHS Trust","author":"Grant","year":"2020","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cmi.2021.06.023_bib32","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1038\/s41467-020-17703-6","article-title":"Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion","volume":"11","author":"Simon","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.cmi.2021.06.023_bib33","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2020.080","article-title":"Seroprevalence of anti-SARS-CoV2 antibodies in Umbrian persons living with HIV","volume":"12","author":"Papalini","year":"2020","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.cmi.2021.06.023_bib34","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s15010-020-01564-8","article-title":"HIV and SARS-CoV-2 co-infection: cross-sectional findings from a German 'hotspot","volume":"49","author":"Noe","year":"2021","journal-title":"Infection"},{"key":"10.1016\/j.cmi.2021.06.023_bib35","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.eimc.2011.06.002","article-title":"[The Cohort of the Spanish HIV Research Network (CoRIS) and its associated biobank; organizational issues, main findings and losses to follow-up]","volume":"29","author":"Sobrino-Vegas","year":"2011","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.cmi.2021.06.023_bib36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1742-4690-6-27","article-title":"The Spanish HIV BioBank: a model of cooperative HIV research","volume":"6","author":"Garcia-Merino","year":"2009","journal-title":"Retrovirology"},{"key":"10.1016\/j.cmi.2021.06.023_bib37","series-title":"COVID-19 treatment guidelines","year":"2020"},{"key":"10.1016\/j.cmi.2021.06.023_bib38","doi-asserted-by":"crossref","first-page":"i1981","DOI":"10.1136\/bmj.i1981","article-title":"Sparse data bias: a problem hiding in plain sight","volume":"352","author":"Greenland","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2021.06.023_bib39","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/jmv.26211","article-title":"Diagnostic efficacy of anti-SARS-CoV-2 IgG\/IgM test for COVID-19: a meta-analysis","volume":"93","author":"Zhang","year":"2021","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.cmi.2021.06.023_bib40","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1080\/22221751.2020.1826362","article-title":"Meta-analysis of diagnostic performance of serology tests for COVID-19: impact of assay design and post-symptom-onset intervals","volume":"9","author":"Wang","year":"2020","journal-title":"Emerg Microbe. Infect"},{"key":"10.1016\/j.cmi.2021.06.023_bib41","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/jmv.26303","article-title":"Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA, and IgM antibodies","volume":"93","author":"Tre-Hardy","year":"2021","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.cmi.2021.06.023_bib42","doi-asserted-by":"crossref","first-page":"104569","DOI":"10.1016\/j.jcv.2020.104569","article-title":"Comparison of different serological assays for SARS-CoV-2 in real life","volume":"130","author":"Brochot","year":"2020","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.cmi.2021.06.023_bib43","first-page":"M20","article-title":"The proportion of SARS-CoV-2 infections that are asymptomatic : a systematic review","author":"Oran","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cmi.2021.06.023_bib44","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1001\/jama.2020.8598","article-title":"COVID-19 and racial\/ethnic disparities","volume":"323","author":"Webb Hooper","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2021.06.023_bib45","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1021\/acs.jproteome.0c00392","article-title":"Nucleotide analogues as inhibitors of SARS-CoV-2 polymerase, a key drug target for COVID-19","volume":"19","author":"Chien","year":"2020","journal-title":"J\u00a0Proteome Res"},{"key":"10.1016\/j.cmi.2021.06.023_bib46","article-title":"Tenofovir Disoproxil Fumarate: new chemical developments and encouraging in\u00a0vitro biological results for SARS-CoV-2","volume":"31","author":"Clososki","year":"2020","journal-title":"J\u00a0Braz Chem Soc"},{"key":"10.1016\/j.cmi.2021.06.023_bib47","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01114-20","article-title":"Antiviral efficacies of FDA-approved drugs against SARS-CoV-2 infection in ferrets","volume":"11","author":"Park","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.cmi.2021.06.023_bib48","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/jac\/dkt532","article-title":"Phase I\/II study of the pharmacokinetics, safety and antiretroviral activity of tenofovir alafenamide, a new prodrug of the HIV reverse transcriptase inhibitor tenofovir, in HIV-infected adults","volume":"69","author":"Markowitz","year":"2014","journal-title":"J\u00a0Antimicrob Chemother"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X21003438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X21003438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:30:14Z","timestamp":1761118214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X21003438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1198743X21003438"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2021.06.023","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2021.06.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}